Literature DB >> 9695127

Behavioral and physiological consequences of repeated daily intracerebroventricular injection of corticotropin-releasing factor in the rat.

B Buwalda1, A A Van Kalkeren, S F de Boer, J M Koolhaas.   

Abstract

The present study was conducted to investigate the long-term consequences of repeated daily bolus injections of corticotropin-releasing factor (CRF) intracerebroventricularly (ICV) on ongoing locomotor activity and physiology in the home cage of individually housed rats. For this purpose ovine CRF (1 microgram/3 microliters) was injected once daily during the early resting phase into the lateral ventricle for a period of 10 days. Changes in daily rhythms in heart rate, body temperature and motor activity were recorded telemetrically before and during the treatment period. Daily central CRF injection delayed the body weight gain, increased adrenal weight, and decreased the weight of the thymus at the end of the experiment. The acute behavioral and physiological responses to CRF did not habituate with repetition of treatment. CRF treatment also failed to affect the long-term regulation of baseline heart rate, body temperature and motor activity during the light phase, as measured during the hour preceding the daily CRF injection. Mean heart rate during the dark phase was, however, significantly decreased in CRF-treated rats during the whole experimental 10-day period, without any sign of habituation. The failure of episodic CRF to affect long-term regulation of baseline body temperature during the light as well as the dark phase was noteworthy because an increased daytime body temperature lasting for several days is a characteristic marker of various behavioral stressors. Since a previous study showed that the temperature response during chronic CRF infusion was similar to the long-term effects of behavioral stress it is hypothesized that chronic but not episodic increases in central CRF levels are related to the induction and persistence of part of the stress-related behavioral and physiological disorders.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9695127     DOI: 10.1016/s0306-4530(97)00096-6

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.905


  6 in total

1.  Do centrally administered neuropeptides access cognate receptors?: an analysis in the central corticotropin-releasing factor system.

Authors:  J C Bittencourt; P E Sawchenko
Journal:  J Neurosci       Date:  2000-02-01       Impact factor: 6.167

2.  Chronic overexpression of corticotropin-releasing factor from the central amygdala produces HPA axis hyperactivity and behavioral anxiety associated with gene-expression changes in the hippocampus and paraventricular nucleus of the hypothalamus.

Authors:  Elizabeth I Flandreau; Kerry J Ressler; Michael J Owens; Charles B Nemeroff
Journal:  Psychoneuroendocrinology       Date:  2011-05-26       Impact factor: 4.905

3.  Excitotoxic lesions of the bed nucleus of the stria terminalis (BNST) attenuate the effects of repeated stress on weight gain: evidence for the recruitment of BNST activity by repeated, but not acute, stress.

Authors:  Carolyn W Roman; Kimberly R Lezak; Margaret Kocho-Schellenberg; Mark A Garret; Karen Braas; Victor May; Sayamwong E Hammack
Journal:  Behav Brain Res       Date:  2011-11-15       Impact factor: 3.332

4.  Central injections of CRF reinstate cocaine seeking in rats after postinjection delays of up to 3 h: an influence of time and environmental context.

Authors:  Suzanne Erb; Ana Petrovic; Daniel Yi; Hanan Kayyali
Journal:  Psychopharmacology (Berl)       Date:  2006-05-03       Impact factor: 4.530

5.  The effects of repeated intra-amygdala CRF injections on rat behavior and HPA axis function after stress.

Authors:  W M U Daniels; L Richter; D J Stein
Journal:  Metab Brain Dis       Date:  2004-06       Impact factor: 3.584

6.  PVN pathways controlling energy homeostasis.

Authors:  Jennifer W Hill
Journal:  Indian J Endocrinol Metab       Date:  2012-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.